Trevena (TRVN) Competitors $0.97 +0.06 (+6.59%) As of 02:23 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock TRVN vs. TTNP, PLRZ, EVOK, LIPO, DRMA, VIVS, CMND, CANF, ARTL, and CEROShould you be buying Trevena stock or one of its competitors? The main competitors of Trevena include Titan Pharmaceuticals (TTNP), Polyrizon (PLRZ), Evoke Pharma (EVOK), Lipella Pharmaceuticals (LIPO), Dermata Therapeutics (DRMA), VivoSim Labs (VIVS), Clearmind Medicine (CMND), Can-Fite BioPharma (CANF), Artelo Biosciences (ARTL), and CERo Therapeutics (CERO). These companies are all part of the "pharmaceutical products" industry. Trevena vs. Its Competitors Titan Pharmaceuticals Polyrizon Evoke Pharma Lipella Pharmaceuticals Dermata Therapeutics VivoSim Labs Clearmind Medicine Can-Fite BioPharma Artelo Biosciences CERo Therapeutics Titan Pharmaceuticals (NASDAQ:TTNP) and Trevena (NASDAQ:TRVN) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends. Do analysts recommend TTNP or TRVN? Trevena has a consensus target price of $5.00, indicating a potential upside of 415.46%. Given Trevena's stronger consensus rating and higher possible upside, analysts plainly believe Trevena is more favorable than Titan Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Trevena 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media prefer TTNP or TRVN? In the previous week, Titan Pharmaceuticals and Titan Pharmaceuticals both had 1 articles in the media. Titan Pharmaceuticals' average media sentiment score of 0.00 equaled Trevena'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Titan Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Trevena 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is TTNP or TRVN more profitable? Trevena's return on equity of 0.00% beat Titan Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Titan PharmaceuticalsN/A -145.92% -129.20% Trevena N/A N/A -119.55% Which has more risk and volatility, TTNP or TRVN? Titan Pharmaceuticals has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500. Comparatively, Trevena has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500. Which has higher valuation & earnings, TTNP or TRVN? Titan Pharmaceuticals has higher earnings, but lower revenue than Trevena. Titan Pharmaceuticals is trading at a lower price-to-earnings ratio than Trevena, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTitan Pharmaceuticals$180K22.37-$4.71M-$4.59-0.96Trevena$443K2.10-$40.29M-$47.04-0.02 Do insiders and institutionals believe in TTNP or TRVN? 31.5% of Titan Pharmaceuticals shares are owned by institutional investors. Comparatively, 13.6% of Trevena shares are owned by institutional investors. 0.7% of Titan Pharmaceuticals shares are owned by insiders. Comparatively, 2.7% of Trevena shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryTrevena beats Titan Pharmaceuticals on 7 of the 12 factors compared between the two stocks. Get Trevena News Delivered to You Automatically Sign up to receive the latest news and ratings for TRVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TRVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRVN vs. The Competition Export to ExcelMetricTrevenaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$930K$790.52M$5.54B$8.99BDividend YieldN/A4.84%5.25%4.04%P/E Ratio-0.021.3027.5520.17Price / Sales2.10225.41432.66125.29Price / CashN/A23.4436.8257.86Price / Book-0.096.138.105.60Net Income-$40.29M-$27.58M$3.17B$248.58M7 Day Performance-11.82%1.19%4.21%5.33%1 Month Performance-4.90%8.40%3.85%7.26%1 Year Performance-82.04%7.15%34.49%21.87% Trevena Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRVNTrevena1.5947 of 5 stars$0.97+6.6%$5.00+415.5%-83.0%$930K$443K-0.0240News CoverageGap DownTTNPTitan Pharmaceuticals0.0935 of 5 stars$4.20-4.5%N/A-13.6%$4.02M$180K-0.9210PLRZPolyrizonN/A$0.740.0%N/AN/A$3.94MN/A0.00N/AEVOKEvoke Pharma0.3417 of 5 stars$2.60-1.1%N/A-59.0%$3.92M$10.25M-0.914News CoverageGap UpLIPOLipella Pharmaceuticals1.5135 of 5 stars$0.87-3.6%N/A-77.5%$3.88M$536.36K-0.214DRMADermata Therapeutics1.9991 of 5 stars$0.59-3.2%$3.00+412.8%-72.7%$3.85MN/A-0.048News CoveragePositive NewsGap UpVIVSVivoSim LabsN/A$1.47flatN/AN/A$3.82M$140K-0.1420Positive NewsCMNDClearmind Medicine0.6373 of 5 stars$0.90+1.2%N/A-37.6%$3.79MN/A-0.82N/ACANFCan-Fite BioPharma3.2727 of 5 stars$1.05+1.0%$14.00+1,233.3%-60.1%$3.72M$674K-0.598ARTLArtelo Biosciences3.1455 of 5 stars$13.27+95.4%$33.00+148.7%+100.7%$3.71MN/A-0.745News CoverageAnalyst UpgradeGap UpHigh Trading VolumeCEROCERo Therapeutics3.6529 of 5 stars$9.63+0.8%$45.00+367.3%-97.9%$3.69MN/A0.008Gap Up Related Companies and Tools Related Companies TTNP Alternatives PLRZ Alternatives EVOK Alternatives LIPO Alternatives DRMA Alternatives VIVS Alternatives CMND Alternatives CANF Alternatives ARTL Alternatives CERO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TRVN) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevena, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevena With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRVN Stock Alerts